Armata Pharmaceuticals (ARMP) Cash & Equivalents (2016 - 2018)
Historic Cash & Equivalents for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $13.4 million.
- Armata Pharmaceuticals' Cash & Equivalents rose 7337.22% to $13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $13.4 million, marking a year-over-year increase of 7337.22%. This contributed to the annual value of $5.1 million for FY2017, which is 0.0% changed from last year.
- As of Q3 2018, Armata Pharmaceuticals' Cash & Equivalents stood at $13.4 million, which was up 7337.22% from $15.4 million recorded in Q2 2018.
- Armata Pharmaceuticals' 5-year Cash & Equivalents high stood at $16.6 million for Q1 2015, and its period low was $2.2 million during Q1 2017.
- Its 5-year average for Cash & Equivalents is $9.5 million, with a median of $9.0 million in 2017.
- The largest annual percentage gain for Armata Pharmaceuticals' Cash & Equivalents in the last 5 years was 218581.36% (2014), contrasted with its biggest fall of 6766.89% (2014).
- Over the past 5 years, Armata Pharmaceuticals' Cash & Equivalents (Quarter) stood at $6.6 million in 2014, then skyrocketed by 42.38% to $9.4 million in 2015, then plummeted by 45.23% to $5.1 million in 2016, then changed by 0.0% to $5.1 million in 2017, then surged by 160.97% to $13.4 million in 2018.
- Its last three reported values are $13.4 million in Q3 2018, $15.4 million for Q2 2018, and $8.2 million during Q1 2018.